BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10831279)

  • 1. Toxicity of anticancer agents mediated by electroporation in vitro.
    Jaroszeski MJ; Dang V; Pottinger C; Hickey J; Gilbert R; Heller R
    Anticancer Drugs; 2000 Mar; 11(3):201-8. PubMed ID: 10831279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy.
    Cemazar M; Parkins CS; Holder AL; Chaplin DJ; Tozer GM; Sersa G
    Br J Cancer; 2001 Feb; 84(4):565-70. PubMed ID: 11207055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrochemotherapy against colorectal carcinoma: comparison of in vitro cytotoxicity of 5-fluorouracil, cisplatin and bleomycin.
    Kuriyama S; Matsumoto M; Mitoro A; Tsujinoue H; Toyokawa Y; Nakatani T; Yamazaki M; Okamoto S; Fukui H
    Int J Oncol; 1999 Jul; 15(1):89-94. PubMed ID: 10375598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
    Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
    Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of effects of anticancer agents by local electric pulses in murine bladder cancer.
    Ogihara M; Yamaguchi O
    Urol Res; 2000 Dec; 28(6):391-7. PubMed ID: 11221918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells.
    Horikoshi T; Naganuma H; Ohashi Y; Ueno T; Nukui H
    Brain Res Bull; 2000 Mar; 51(5):371-8. PubMed ID: 10715556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment.
    Neal RE; Rossmeisl JH; D'Alfonso V; Robertson JL; Garcia PA; Elankumaran S; Davalos RV
    Ann Biomed Eng; 2014 Mar; 42(3):475-87. PubMed ID: 24165928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Cisplatin Electrochemotherapy on Human Neuroblastoma Cells.
    Esmekaya MA; Kayhan H; Coskun A; Canseven AG
    J Membr Biol; 2016 Oct; 249(5):601-610. PubMed ID: 27021229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cytotoxicity of bleomycin, cisplatin, and carboplatin on equine sarcoid cells following electroporation-mediated delivery in vitro.
    Souza C; Villarino NF; Farnsworth K; Black ME
    J Vet Pharmacol Ther; 2017 Jan; 40(1):97-100. PubMed ID: 27287308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.
    Girelli R; Prejanò S; Cataldo I; Corbo V; Martini L; Scarpa A; Claudio B
    Radiol Oncol; 2015 Jun; 49(2):147-54. PubMed ID: 26029026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cervical cancer by electrochemotherapy with bleomycin, cisplatin, and calcium: an in vitro experimental study.
    Gursoy G; Esmekaya MA; Cicek Z
    Med Oncol; 2022 Dec; 40(1):52. PubMed ID: 36527530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of electroporation in increasing the effectiveness of anticancer drugs].
    Labanauskiene J; Didziapetriene J; Aleknavicius E
    Medicina (Kaunas); 2006; 42(1):33-7. PubMed ID: 16467611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs.
    Gehl J; Skovsgaard T; Mir LM
    Anticancer Drugs; 1998 Apr; 9(4):319-25. PubMed ID: 9635922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro.
    Saczko J; Kamińska I; Kotulska M; Bar J; Choromańska A; Rembiałkowska N; Bieżuńska-Kusiak K; Rossowska J; Nowakowska D; Kulbacka J
    Biomed Pharmacother; 2014 Jun; 68(5):573-80. PubMed ID: 24975085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes.
    Vižintin A; Marković S; Ščančar J; Miklavčič D
    Bioelectrochemistry; 2021 Aug; 140():107798. PubMed ID: 33743336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model.
    Nanda GS; Sun FX; Hofmann GA; Hoffman RM; Dev SB
    Anticancer Res; 1998; 18(3A):1361-6. PubMed ID: 9673341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
    Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
    Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization).
    Rabussay DP; Nanda GS; Goldfarb PM
    Technol Cancer Res Treat; 2002 Feb; 1(1):71-82. PubMed ID: 12614180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach.
    Testori A; Tosti G; Martinoli C; Spadola G; Cataldo F; Verrecchia F; Baldini F; Mosconi M; Soteldo J; Tedeschi I; Passoni C; Pari C; Di Pietro A; Ferrucci PF
    Dermatol Ther; 2010; 23(6):651-61. PubMed ID: 21054709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of various human cancer cell lines to nanosecond and microsecond range electrochemotherapy: Feasibility of multi-drug cocktails.
    Rembiałkowska N; Novickij V; Radzevičiūtė-Valčiukė E; Mickevičiūtė E; Gajewska-Naryniecka A; Kulbacka J
    Int J Pharm; 2023 Nov; 646():123485. PubMed ID: 37802257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.